The AIDS epidemic.
The nature of the clinical presentation of HIV infection continues to evolve over time. New cutaneous (e.g., seborrheic dermatitis, onychomycosis, and tinea pedis) and systemic (e.g., Aspergillus fumigatus and Penicillium marneffei) opportunistic fungal infections can now be added to the classic clinical markers for progressive HIV infection, such as Kaposi's sarcoma, Pneumocystis carinii pneumonia, Mycobacterium avium intercellulare infections, and cryptococcal meningitis. The fact that the appearance of many of these fungal diseases is directly correlated with the patient's CD4 cell count is a valuable tool for ongoing clinical evaluation. Although systemic manifestations characterize a progression from asymptomatic HIV infection to AIDS, many of the signs of disease progression are cutaneous. Prophylaxis against many of the potentially life-threatening systemic opportunistic infections associated with HIV positivity has had a positive impact on the life expectancy of patients with AIDS.
Conant
M A
MA
Department of Dermatology, University of California, San Francisco.
D017088:AIDS-Related Opportunistic Infections / Q000150:complications / Q000188:drug therapy / Q000453:epidemiology*; D000163:Acquired Immunodeficiency Syndrome / Q000150:complications / Q000188:drug therapy / Q000453:epidemiology* / Q000276:immunology; D000935:Antifungal Agents / Q000627:therapeutic use; D003883:Arthrodermataceae / Q000472:pathogenicity; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology; D003881:Dermatomycoses / Q000150:complications / Q000188:drug therapy / Q000453:epidemiology* / Q000276:immunology; D004802:Eosinophilia / Q000150:complications / Q000453:epidemiology* / Q000276:immunology; D005499:Folliculitis / Q000150:complications / Q000453:epidemiology* / Q000276:immunology; D006801:Humans; D015994:Incidence; D007958:Leukocyte Count
D000935:Antifungal Agents